Posted April 10, 2020
In our effort to expose our readership to alternative views on the current COVID19 crisis, we want to feature the work of another scientist who does not follow the narrative being given to the public by our government officials and the corporate-sponsored “mainstream” media. Dr. Shiva Ayyadurai has a long list of credentials that should allow him to have a voice in the current COVID19 pandemic, but it is highly unlikely you will come across his views outside of the alternative media. Dr. Shiva is the inventor of email and polymath, and holds four degrees from MIT. Read more.
Get Informed on Issues Related to Drugs
Modern Medicine Knew of Zinc for Coronavirus Infections a Decade Ago but Failed to Put Into Practice
Posted April 10, 2020
The long-standing bias against natural over patentable synthetic molecules in the practice of medicine has now resulted in the avoidable premature death of thousands of the most vulnerable individuals and the abrupt and near-complete economic collapse of modern society due to an unwarranted over-response by health authorities, political overseers and sensationalist news media. Read more.
Media Censoring Medical Doctors Saving Lives with Vitamin C for COVID-19 — Reduces need for Ventilators
Posted April 10, 2020
The vitamin C is a combination therapy developed in 2017 by Dr. Paul Marik at Eastern Virginia Medical School. He gives critically ill patients IV doses of hydrocortisone, vitamin C, and vitamin B1 within six hours of entering the emergency room. Dr. Marik reported a significantly lowered death rate in those treated with his regimen. Read more.
Why You Don’t Want to Take Aspirin or Motrin for COVID-19
Posted April 3, 2020
If you’ve been following the news about the novel coronavirus COVID-19 (sometimes also referred to as SARS-CoV-2, due to its similarities to SARS), you’ve probably seen articles offering conflicting information about the use of ibuprofen.1 Some say taking ibuprofen may aggravate COVID-19 infection while others say there’s no such risk. For example, March 18, 2020, CNN reported2 the health minister of France, Oliver Veran, is warning against using nonsteroidal anti-inflammatories (NSAIDs) such as ibuprofen to treat fever and pain associated with COVID-19 infection, and to use acetaminophen (paracetamol) instead. Read more.
COVID-19 Related Drug Shortages in U.S. Because China Supplies Most Ingredients
Posted April 3, 2020
The United States Food and Drug Administration (FDA) has reported its first shortage of a drug in the United States due to the novel coronavirus (COVID-19) outbreak that began in China in December 2019 and, by March 11, 2020, had been declared a global pandemic by the World Health Organization (WHO). Read more.
Antimalarial Medications: A COVID-19 Treatment Option?
Posted April 3, 2020
The outbreak of the most recent iteration of coronavirus — COVID-19 — has experts scrambling to find effective methods of delivering supportive care and minimizing the effect of the illness. As Dr. Roger Seheult, co-founder of MedCram.com, explains in this short video, several factors have been responsible for the rapid spread. One of the drugs currently under investigation is chloroquine, a treatment commonly used to keep malaria in check. Chloroquine is a synthetic derivative of quinine, which was once the only treatment for malaria. However, quinine is bitter and has significant side effects. Read more.
12 Doctors and Scientists Express Doubts and Concerns over the Draconian Response to COVID-19
Posted March 27, 2020
Twelve medical experts express doubts and concerns over the official narrative for the Coronavirus. Their concerns include: the fact that destruction of the economy will cause more deaths than the coronavirus, the fact that there are no scientific standards for testing for the presence of the virus, the fact that most deaths are only in the elderly population, the fact that children are prevented from developing immunity by closing schools, the fact that more people die from traditional flu than COVID-19, and the fact that, in Italy, a lockdown failed to slow the spread of the disease. This includes video statements from two doctors in Germany that, are well worth watching even though you may have to read the English translation at the bottom of the screen. Read more.
What We Can Learn From A Pandemic “Tabletop Exercise”?
Posted March 27, 2020
We are living in unfamiliar times. We are frightened by the highly infectious coronavirus CoV-2019 or COVID-19, and our hearts go out to those who have been directly affected. We are in a global “lockdown,” “sheltering in place,” against an invisible but potentially deadly enemy. Our world has changed rapidly and dramatically since the World Health Organization (WHO) declared a pandemic on March 11, 2020. Read more.
A Brief History of Chloroquine
Posted March 27, 2020
On March 16, 2020, US President Donald Trump announced during a press conference that chloroquine and hydroxychloroquine have shown “encouraging early results [against the coronavirus],” and that “we’re going to be able to make that drug available almost immediately.” The statement was later clarified by US Food and Drug Administration (FDA) Commissioner Stephen Hahn, MD, who said that chloroquine was “already approved for the treatment of malaria, as well as an arthritis condition. That’s a drug that the president has directed us to take a closer look at, as to whether an expanded use approach to that could be done to actually see if that benefits patients. And again, we want to do that in the setting of a clinical trial, a large pragmatic clinical trial to actually gather that information and answer the question that needs to be answered. Read more.
A Bill We Helped Write Might Hold Key for COVID-19
Posted March 27, 2020
The COVID-19 pandemic has medical professionals scrambling to see what treatments they can offer patients. The latest estimates are that a vaccine is at least a year away. The World Health Organization has identified one drug that may offer some hope: an experimental drug called Remdesivir. The drug was effective against viral infections in the laboratory and in animal experiments but failed in an Ebola trial. It is currently being tested on the coronavirus in China and the US, among other places. Read more.
